Dana Investment Advisors, Inc.
Position in IONS — Ionis Pharmaceuticals Inc
CIK 1427514
BROOKFIELD, WI
Position in IONS
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$1,388,188
-$37,848 QoQ
Shares Held
18,487
+2.6% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2025
3 quarters on record
Voting authority
Sole 96.63006436955699.ToString("F0")%
Shared 0.ToString("F0")%
None 3.369935630443014.ToString("F0")%
Common Shares in IONS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Dana Investment Advisors, Inc. holds $35,335,939 across 12 Biotechnology names. IONS ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LGND |
Ligand Pharmaceuticals Inc
|
69,234 | $13,822,568 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
8,397 | $6,487,858 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
26,379 | $4,458,578 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
59,756 | $1,944,460 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,197 | $1,673,533 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
43,954 | $1,460,151 | |
| 7 | ZYME |
Zymeworks Inc.
|
56,107 | $1,404,919 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
This page
|
18,487 | $1,388,188 |
All Filings in IONS
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,388,188 | 18,487 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $1,426,036 | 18,026 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $1,231,073 | 18,818 | Shares | Sole | 2025-11-10 | |
| No filing history on record for this holder in this stock. | ||||||